German pharmaceutical industry in a battle it cannot win
This article was originally published in Scrip
Executive Summary
Germany’s pharmaceutical companies and the country’s main doctors’ association have once again come to blows. The German pharmaceutical industry association, the BPI, has complained that a new agreement signed between the Federal Association of Statutory Health Insurance Physicians (KBV) and the health insurance funds compromises patient care and threatens doctors with financial penalties.